Financhill
Back

Akebia Therapeutics Vs. Eli Lilly and Industry Stock Comparison

Buy
66

AKBA
Akebia Therapeutics

Last Price:
2.05
Seasonality Move:
46.76%
Sell
47

LLY
Eli Lilly and

Last Price:
789.25
Seasonality Move:
4.13%
Buy
66
Akebia Therapeutics (AKBA) is a Buy

Is Akebia Therapeutics a Buy, Sell or Hold?

  • The current Akebia Therapeutics [AKBA] share price is $1.93. The Score for AKBA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • AKBA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Eli Lilly and (LLY) is a Sell

Is Eli Lilly and a Buy, Sell or Hold?

  • The current Eli Lilly and [LLY] share price is $755.00. The Score for LLY is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • LLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKBA Stock Price Chart

What is Akebia Therapeutics's stock price today?

  • The Akebia Therapeutics share price today is $1.93
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKBA is experiencing slight buying pressure.

LLY Stock Price Chart

What is Eli Lilly and's stock price today?

  • The Eli Lilly and share price today is $755.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKBA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 63.93 Buy
Chaikin Money Flow: 283199 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.66 - 1.92) Buy
Bollinger Bands (100): (1.23 - 1.69) Buy

LLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -35.95 Sell
Relative Strength Index (14 RSI): 34.67 Sell
Chaikin Money Flow: 5583528 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (756.97 - 872.43) Sell
Bollinger Bands (100): (816.69 - 941.19) Sell

AKBA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.84 Buy
20-day SMA: 1.84 Buy
50-day SMA: 1.56 Buy
200-day SMA: 1.41 Buy
8-day EMA: 1.86 Buy
20-day EMA: 1.8 Buy
50-day EMA: 1.64 Buy
200-day EMA: 1.41 Buy

LLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 749.46 Buy
20-day SMA: 793.77 Sell
50-day SMA: 861.71 Sell
200-day SMA: 835.02 Sell
8-day EMA: 758.72 Sell
20-day EMA: 792.27 Sell
50-day EMA: 838.73 Sell
200-day EMA: 810.55 Sell

Akebia Therapeutics Earnings Growth & AKBA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.07 per share.

Eli Lilly and Earnings Growth & LLY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.88 per share, and an increase next year of $9.44 per share.

Akebia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Eli Lilly and Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):